Abstract: This invention generally relates to liquid phase oxidation processes for making N-(phosphonomethyl)glycine (also known in the agricultural chemical industry as glyphosate) and related compounds. This invention, for example, particularly relates to processes wherein an N-(phosphonomethyl)iminodiacetic acid (NPMIDA) substrate (i.e., N-(phosphonomethyl)iminodiacetic acid, a salt of N-(phosphonomethyl)iminodiacetic acid, or an ester of N-(phosphonomethyl)iminodiacetic acid) is continuously oxidized to form an N-(phosphonomethyl)glycine product (i.e., N-(phosphonomethyl)glycine, a salt of N-(phosphonomethyl)glycine, or an ester of N-(phosphonomethyl)glycine). This invention also, for example, particularly relates to processes wherein an N-(phosphonomethyl)iminodiacetic acid substrate is oxidized to form an N-(phosphonomethyl)glycine product, which, in turn, is crystallized (at least in part) in an adiabatic crystallizer.

Abstract: This invention generally relates to liquid phase oxidation processes for making N-(phosphonomethyl)glycine (also known in the agricultural chemical industry as glyphosate) and related compounds. This invention, for example, particularly relates to processes wherein an N-(phosphonomethyl)iminodiacetic acid (NPMIDA) substrate (i.e., N-(phosphonomethyl)iminodiacetic acid, a salt of N-(phosphonomethyl)iminodiacetic acid, or an ester of N-(phosphonomethyl)iminodiacetic acid) is continuously oxidized to form an N-(phosphonomethyl)glycine product (i.e., N-(phosphonomethyl)glycine, a salt of N-(phosphonomethyl)glycine, or an ester of N-(phosphonomethyl)glycine). This invention also, for example, particularly relates to processes wherein an N-(phosphonomethyl)iminodiacetic acid substrate is oxidized to form an N-(phosphonomethyl)glycine product, which, in turn, is crystallized (at least in part) in an adiabatic crystallizer.

Abstract: Implantable medical devices (IMDS) having anti-infective properties are described. Anti-infective agents are disposed in, on, or about at least a portion of a surface of the medical device. The anti-infective agents are disposed in or on a vehicle, which may be in the form of a coating layer or covering. The vehicle may be biodegradable so that, over time, the anti-infective agent is removed from a tissue location into which the device is implanted, reducing the likelihood that microorganisms resistant to the anti-infective agent will develop. IMDs having an anti-infective agent and an anti-activity agent disposed therein, thereabout, or thereon are also described. The anti-activity agent interferes with the activity of the anti-infective agent, may be released from a surface at the IMD at a time when activity of the anti-infective agent is no longer desired, and may reduce the likelihood that microorganisms resistant to the anti-infective agent will develop.

Abstract: An anti-infective covering for an implantable medical device is described. The covering may be a polymeric boot that comprises an anti-infective agent in an amount effective to prevent an infection when implanted in a pocket of a patient. The boot is configured to snuggly engage at least a portion of the implantable medical device. The boot may contain a side hole that allows a housing of the implantable medical device to serve as a return electrode. The boot may be placed about the implantable medical device to render the device anti-infective.

Abstract: A system, method and apparatus relating to a therapeutic substance delivery patch for attachment to a patient such that the patch is in contact with the patient's skin, wherein the patch coordinates its delivery of the therapeutic substance to the patient based on information received relating to the operation of the implanted device. The information received by the patch may be received through telemetry from the implanted device, or alternatively from the patch sensing the action of the implanted device, or alternatively from the patch sensing the patient's physiologic reaction to the action taken by the implanted device.

Abstract: A bed foundation has a rectangular top panel and opposite side and end panels depending downwardly from the top panel to form a box-like enclosure having an open lower end, the panels being formed integrally. A support structure of raised ribs in a predetermined regular pattern is formed integrally on the lower surface of the top panel. The foundation is made entirely or substantially entirely from an expanded rigid plastic foam material with high flame retardancy.

Abstract: A bed foundation is provided by a rectangular panel having a flat upper face and downwardly depending side and end walls to form an open box-like structure. Downwardly facing mounting bores are provided at least at the corners of the foundation, and support legs are engaged in the bores to support the foundation at a spacing above a floor surface. The foundation is made entirely or substantially entirely from an expanded rigid plastic foam material with high flame retardancy. In an alternative, the side and end walls are eliminated and the legs are supported directly at the corners of a single flat panel, with springs tacked to the upper surface and surrounded by a suitable cover.

Abstract: This invention generally relates to liquid phase oxidation processes for making N-(phosphonomethyl)glycine (also known in the agricultural chemical industry as glyphosate) and related compounds. This invention, for example, particularly relates to processes wherein an N-(phosphonomethyl)iminodiacetic acid (NPMIDA) substrate (i.e., N-(phosphonomethyl)iminodiacetic acid, a salt of N-(phosphonomethyl)iminodiacetic acid, or an ester of N-(phosphonomethyl)iminodiacetic acid) is continuously oxidized to form an N-(phosphonomethyl)glycine product (i.e., N-(phosphonomethyl)glycine, a salt of N-(phosphonomethyl)glycine, or an ester of N-(phosphonomethyl)glycine). This invention also, for example, particularly relates to processes wherein an N-(phosphonomethyl)iminodiacetic acid substrate is oxidized to form an N-(phosphonomethyl)glycine product, which, in turn, is crystallized (at least in part) in an adiabatic crystallizer.

Abstract: A plague board comprises a solid polyurethane core enclosed by a high grade wood which forms all exterior surfaces thereof. A wooden frame is secured between the peripheries of a pair of spaced panels formed of flat sheets of veneer. The polyurethane core fills the interior of the frame between the veneer panels and is firmly bonded to the wooden frame and veneer. A method disclosed for constructing the plaque board and other like articles comprises inserting a measured amount of liquid polyurethane foam in the interior space between the attached frame and panels and pressing the opposite veneer panels inwardly as the polyurethane expands outwardly to solidify and become bonded to the frame and panels.